| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |